“Let the Beauty of What You Love Be What You Do.”
Genomic data is being integrated into clinical trials—sometimes not so successfully, and sometimes very, very successfully.
Cancer therapies dominate 40% of the global clinical pipeline, and the field of oncology is leading the precision medicine revolution.
The world's oncology pipeline is rapidly growing, with nearly 40% of the global clinical pipeline focused on immuno-oncology.
Challenge #1: An Abundance of Biomarker Data